Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 2nd article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Professor Seebacher, a leading dermatomycologist, always warned us never to end onychomycosis therapy too early. Here are the reasons: Mycosis does not confer immunity. But, above all, […]
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 1st article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Mycology is one of the most beautiful faces of dermatology. To admire T. soudanense, T. violaceum or T. benhamiae in a Petri dish is an aesthetic enjoyment.
Recently, a very interesting review article on the diagnostics of bullous dermatoses has been published in Frontiers of Immunology, a peer-reviewed journal. The publication is authored by EUROIMMUN scientists, who were invited to write an expert review article on this important topic. Over the past few years, EUROIMMUN has become a true leader in this
They are nasty: they are itching, they scale, inflame, hurt and really do not look nice – fungal skin and nail infections! And not only the therapy may turn into a test of patience, if it, as it happens so often, requires application for several months. Also diagnosis of infection and identification of the pathogen
Bullous pemphigoid (BP) is considered the most frequent autoimmune blistering disease with an incidence of about 1.5 to 2 per 100,000 inhabitants and year in the general population. The disease becomes even more frequent in the elderly. The clinical picture of BP includes tense blisters, formation of erythema, erosions, crusts and pruritus. The presence of